InvestmentPitch Media Video Discusses MindBio Therapeutics’ Clinical Trials of LSD-Microdosing Reveals Significant Positive Impact on Quality of Sleep VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO) (FSE:WF6), a Melbourne, Australia-based leader in microdosing psychedelic medicines, announced a...

InvestmentPitch Media Video Discusses MindBio Therapeutics’ Receipt of Initial Shipment of 1,000,000 Microdoses of LSD for Phase 2 Clinical Trials for Depression VANCOUVER, British Columbia, May 31, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO) (FSE:WF6), a Melbourne, Australia-based leader in microdosing psychedelic medicines, received its...

MULTIMEDIA UPDATE - InvestmentPitch Media Video Discusses MindBio Therapeutics’ Take at Home LSD-Microdosing Clinical Trial Published in Peer Reviewed Paper in Biological Psychiatry VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological...

InvestmentPitch Media Video Discusses MindBio Therapeutics’ Take at Home LSD-Microdosing Clinical Trial Published in Peer Reviewed Paper in Biological Psychiatry VANCOUVER, British Columbia, May 10, 2023 (GLOBE NEWSWIRE) -- MindBio Therapeutics (CSE:MBIO), through its scientific collaborators, has published its first Peer Reviewed Paper in Biological...